Trial intelligence / Profile preview

Factors related with prostaglandin-associated periorbitopathy in glaucoma patients

TCTR20141011001Recruiting

Sponsor: Ratchadaphiseksomphot Endowment Fund
Start: Jun 2014
Countries: 1

Overview

Open-label, single-arm trial in Glaucoma, sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Presence and severity of prostaglandin-associated periorbitopathy (PAP). Started Jun 2014; status: recruiting.

Conditions

Glaucoma

Beyond the preview

Go deeper on TCTR20141011001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20141011001.